|
|
||||||||
Original Research Communication |
1 From the Divisions of Clinical Mass Spectrometry (KDRS, NMB, LZ-N, WTB, BEW, and ASK) and Gastroenterology and Nutrition (JEH), Department of Pediatrics, Childrens Hospital Medical Center, Cincinnati.
Background: The isoflavones daidzein and genistein occur naturally in most soyfoods, conjugated almost exclusively to sugars. Controversy exists regarding the extent of bioavailability of isoflavone glycosides, and the mechanism of intestinal absorption of isoflavones in humans is unclear. Evidence from intestinal perfusion and in vitro cell culture studies indicates that isoflavone glycosides are poorly absorbed, yet isoflavones are bioavailable and appear in high concentrations in plasma, irrespective of whether they are ingested as aglycones or glycoside conjugates.
Objective: The objective was to determine whether isoflavone glycosides are absorbed from the intestine intact and reach the peripheral circulation unchanged.
Design: Plasma was collected at timed intervals before and after healthy adults ingested 50 mg of one of the isoflavone ß-glycosides (daidzin or genistin) or 250 mL soymilk containing mainly isoflavone glycosides. Electrospray ionization mass spectrometry was used to detect daidzin and genistin after solid-phase extraction of these conjugates from plasma. Bioavailability of isoflavones was confirmed by gas chromatographymass spectrometry analysis.
Results: Specific and sensitive electrospray mass spectrometry failed to detect even traces of daidzin or genistin in plasma collected 1, 2, and 8 h after their ingestion as pure compounds or in a soyfood matrix. However, plasma was enriched in isoflavones that were hydrolyzable with a combined ß-glucuronidase and sulfatase enzyme preparation.
Conclusion: Isoflavone glycosides are not absorbed intact across the enterocyte of healthy adults, and their bioavailability requires initial hydrolysis of the sugar moiety by intestinal ß-glucosidases for uptake to the peripheral circulation.
Key Words: Phytoestrogens isoflavones ß-glycosides daidzein genistein daidzin genistin absorption soyfoods soymilk adults
This article has been cited by other articles:
![]() |
K. D. R. Setchell, X. Zhao, S. E. Shoaf, and K. Ragland The Pharmacokinetics of S-(-)Equol Administered as SE5-OH Tablets to Healthy Postmenopausal Women J. Nutr., November 1, 2009; 139(11): 2037 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell, X. Zhao, P. Jha, J. E Heubi, and N. M Brown The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1029 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jamadar-Shroff, M. G. Papich, and S. E. Suter Soy-Derived Isoflavones Inhibit the Growth of Canine Lymphoid Cell Lines Clin. Cancer Res., February 15, 2009; 15(4): 1269 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Gleason, C. M. Carlsson, J. H. Barnet, S. A. Meade, K. D. R. Setchell, C. S. Atwood, S. C. Johnson, M. L. Ries, and S. Asthana A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women Age Ageing, January 1, 2009; 38(1): 86 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hosoda, T. Furuta, A. Yokokawa, K. Ogura, A. Hiratsuka, and K. Ishii Plasma Profiling of Intact Isoflavone Metabolites by High-Performance Liquid Chromatography and Mass Spectrometric Identification of Flavone Glycosides Daidzin and Genistin in Human Plasma after Administration of Kinako Drug Metab. Dispos., August 1, 2008; 36(8): 1485 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maruo, M. Sakamoto, C. Ito, T. Toda, and Y. Benno Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella Int J Syst Evol Microbiol, May 1, 2008; 58(5): 1221 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Rufer, A. Bub, J. Moseneder, P. Winterhalter, M. Sturtz, and S. E Kulling Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1314 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Coxam Current Data with Inulin-Type Fructans and Calcium, Targeting Bone Health in Adults J. Nutr., November 1, 2007; 137(11): 2527S - 2533S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Enokizono, H. Kusuhara, and Y. Sugiyama Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens Mol. Pharmacol., October 1, 2007; 72(4): 967 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Clerici, K. D. R. Setchell, P. M. Battezzati, M. Pirro, V. Giuliano, S. Asciutti, D. Castellani, E. Nardi, G. Sabatino, S. Orlandi, et al. Pasta Naturally Enriched with Isoflavone Aglycons from Soy Germ Reduces Serum Lipids and Improves Markers of Cardiovascular Risk J. Nutr., October 1, 2007; 137(10): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kottra and H. Daniel Flavonoid Glycosides Are Not Transported by the Human Na+/Glucose Transporter When Expressed in Xenopus laevis Oocytes, but Effectively Inhibit Electrogenic Glucose Uptake J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Walsh, S. J Haak, T. Bohn, Q. Tian, S. J Schwartz, and M. L Failla Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1050 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. C. Geuns, J. Buyse, A. Vankeirsbilck, and E. H. M. Temme Metabolism of Stevioside by Healthy Subjects Experimental Biology and Medicine, January 1, 2007; 232(1): 164 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Prasain, J. Xu, M. Kirk, M. Smith Johnson, J. Sfakianos, and S. Barnes Differential Biliary Excretion of Genistein Metabolites Following Intraduodenal and Intravenous Infusion of Genistin in Female Rats J. Nutr., December 1, 2006; 136(12): 2975 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kano, T. Takayanagi, K. Harada, S. Sawada, and F. Ishikawa Bioavailability of Isoflavones after Ingestion of Soy Beverages in Healthy Adults J. Nutr., September 1, 2006; 136(9): 2291 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell and S. J. Cole Method of Defining Equol-Producer Status and Its Frequency among Vegetarians J. Nutr., August 1, 2006; 136(8): 2188 - 2193. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cassidy, J. E. Brown, A. Hawdon, M. S. Faughnan, L. J. King, J. Millward, L. Zimmer-Nechemias, B. Wolfe, and K. D.R. Setchell Factors Affecting the Bioavailability of Soy Isoflavones in Humans after Ingestion of Physiologically Relevant Levels from Different Soy Foods J. Nutr., January 1, 2006; 136(1): 45 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reimann, J. Dierkes, A. Carlsohn, D. Talbot, M. Ferrari, J. Hallund, W. L. Hall, K. Vafeiadou, U. Huebner, F. Branca, et al. Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women J. Nutr., January 1, 2006; 136(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Clavel, M. Fallani, P. Lepage, F. Levenez, J. Mathey, V. Rochet, M. Serezat, M. Sutren, G. Henderson, C. Bennetau-Pelissero, et al. Isoflavones and Functional Foods Alter the Dominant Intestinal Microbiota in Postmenopausal Women J. Nutr., December 1, 2005; 135(12): 2786 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell, C. Clerici, E. D Lephart, S. J Cole, C. Heenan, D. Castellani, B. E Wolfe, L. Nechemias-Zimmer, N. M Brown, T. D Lund, et al. S-Equol, a potent ligand for estrogen receptor {beta}, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1072 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer Plasma Phytoestrogens Are Not Altered by Probiotic Consumption in Postmenopausal Women with and without a History of Breast Cancer J. Nutr., August 1, 2004; 134(8): 1998 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Bemis, J. L. Capodice, M. Desai, R. Buttyan, and A. E. Katz A Concentrated Aglycone Isoflavone Preparation (GCP) That Demonstrates Potent Anti-Prostate Cancer Activity In vitro and In vivo Clin. Cancer Res., August 1, 2004; 10(15): 5282 - 5292. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Kroon, M. N Clifford, A. Crozier, A. J Day, J. L Donovan, C. Manach, and G. Williamson How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 15 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, J. Hu, P. A. Murphy, D. L. Alekel, W. D. Franke, and S. Hendrich Rapid Gut Transit Time and Slow Fecal Isoflavone Disappearance Phenotype Are Associated with Greater Genistein Bioavailability in Women J. Nutr., October 1, 2003; 133(10): 3110 - 3116. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell and E. Lydeking-Olsen Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes J. Nutr., April 1, 2003; 133(4): 1027 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |